Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrates and Hydralazine in HFpEF
NCT01516346Phase 2Completed
- Sponsor
- Corporal Michael J. Crescenz VA Medical Center
- Start
- Jan 2012
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of isosorbide dinitrate, hydralazine in heart failure with preserved ejection fraction (HFpEF), sponsored by Corporal Michael J. Crescenz VA Medical Center. Started Jan 2012; status: completed.
02
Drugs
isosorbide dinitratehydralazine
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT01516346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01516346.